DNA methylation shapes the Polycomb landscape during the exit from naive pluripotency
- 24 October 2024
- journal article
- research article
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 32 (2) , 346-357
Abstract
In mammals, 5-methylcytosine (5mC) and Polycomb repressive complex 2 (PRC2)-deposited histone 3 lysine 27 trimethylation (H3K27me3) are generally mutually exclusive at CpG-rich regions. As mouse embryonic stem cells exit the naive pluripotent state, there is massive gain of 5mC concomitantly with restriction of broad H3K27me3 to 5mC-free, CpG-rich regions. To formally assess how 5mC shapes the H3K27me3 landscape, we profiled the epigenome of naive and differentiated cells in the presence and absence of the DNA methylation machinery. Surprisingly, we found that 5mC accumulation is not required to restrict most H3K27me3 domains. Instead, this 5mC-independent H3K27me3 restriction is mediated by aberrant expression of the PRC2 antagonist Ezhip (encoding EZH inhibitory protein). At the subset of regions where 5mC appears to genuinely supplant H3K27me3, we identified 163 candidate genes that appeared to require 5mC deposition and/or H3K27me3 depletion for their activation in differentiated cells. Using site-directed epigenome editing to directly modulate 5mC levels, we demonstrated that 5mC deposition is sufficient to antagonize H3K27me3 deposition and confer gene activation at individual candidates. Altogether, we systematically measured the antagonistic interplay between 5mC and H3K27me3 in a system that recapitulates early embryonic dynamics. Our results suggest that H3K27me3 restraint depends on 5mC, both directly and indirectly. Our study also implies a noncanonical role of 5mC in gene activation, which may be important not only for normal development but also for cancer progression, as oncogenic cells frequently exhibit dynamic replacement of 5mC for H3K27me3 and vice versa.Keywords
All Related Versions
This publication has 132 references indexed in Scilit:
- Understanding the interplay between CpG island-associated gene promoters and H3K4 methylationBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2020
- Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomasActa Neuropathologica, 2018
- Locus-Specific DNA Methylation Analysis by Targeted Deep Bisulfite Sequencing2018
- DNA methylation reprogramming in cancer: Does it act by re‐configuring the binding landscape of Polycomb repressive complexes?BioEssays, 2013
- Reconstitution of the Mouse Germ Cell Specification Pathway in Culture by Pluripotent Stem CellsCell, 2011
- A Rapid, Reversible, and Tunable Method to Regulate Protein Function in Living Cells Using Synthetic Small MoleculesCell, 2006
- Differential expression of the seven‐pass transmembrane cadherin genes Celsr1‐3 and distribution of the Celsr2 protein during mouse developmentDevelopmental Dynamics, 2002
- Targeted mutation of the DNA methyltransferase gene results in embryonic lethalityCell, 1992
- Repression of genes by DNA methylation depends on CpG density and promoter strength: evidence for involvement of a methyl‐CpG binding protein.The EMBO Journal, 1992
- A fraction of the mouse genome that is derived from islands of nonmethylated, CpG-rich DNACell, 1985